Bioactive materials is a class of medical materials that can be used in various applications such as dentistry, pharmaceutics, cosmetics, and others. They promote the regenerative and reconstruction properties of cells and tissue. These materials are resistant to moisture and wear and tear. In the dental field, bioactive restorative materials have been developed to help patients who suffer from pulpal damage. When a tooth pulp is damaged, bioactive can promote the growth of reparative dentin. This helps solve a long-standing problem in dentistry. Another advantage of bioactive materials is their ability to accelerate bone formation. Calcium ions, released from calcium phosphate-based biomaterials, are near-equivalent to human blood plasma and can affect the function of a target cell or tissue. Similarly, some scaffolds release nanoparticles that modulate immune responses.
The global Bioactive Materials Market is estimated to account for US$ 2,204.6 Mn in terms of value by the end of 2023.
Global Bioactive Materials Market: Drivers
The bioactive materials market is expected to gain momentum in the coming years due to the rising demand for the treatment of chronic diseases. These materials are used for the restoration of damaged tissues and are able to stimulate the growth of new cells. They are used in cosmetics and medical industries to manufacture antibacterial products and dental care products.
Global Bioactive Materials Market: Opportunities
Increased number of surgeries for the replacement of joints and bones, particularly in the United States and Canada, is projected to provide lucrative market opportunities. According to the American College of Surgeons, every year, 15 million Americans have some kind of surgery. Moreover, the increasing prevalence of musculoskeletal diseases is also a key factor contributing to the increase in the number of bioactive materials used in medical procedures.
Global Bioactive Materials Market: Restraints
Issues associated with the biocompatibility of biomaterials is expected to hamper the market growth to some extent. One of the most common problems associated with biomaterials is the development of implant infections. Fortunately, there are several strategies available to address this problem. Among these are local antibiotic release processes and biofilm control.
Global Bioactive Materials Market- Impact of Coronavirus (Covid-19) Pandemic:
During Covid-19 pandemic the industry has faced huge shutdown. Lockdown has negatively impacted industrial transform processes. Major disruption in supply chain and trading patterns in the global bioactive materials industry is severely impacted the market growth.
To know the latest trends and insights prevalent in this market, click the link below:
The global bioactive materials market was valued at US$ 2,015.8 Mn in 2022 and is forecast to reach a value of US$ 4,374.6 Mn by 2030 at a CAGR of 14.75% between 2023 and 2030.
Bioactive Glass segment held dominant position in the global bioactive materials market in 2022, accounting for 34.75% share in terms of value, increasing approval and launch of new products is expected to propel growth of the segment during the forecast period.
Global Bioactive Materials Market Trends:
Increasing investments in the healthcare sector and government support for improving treatment process is a major trend for the global market. According to the American Medical Association, Health spending in the U.S. increased by 9.7% in 2020 to $4.1 trillion or $12,530 per capita. This growth rate is substantially higher than 2019 (4.3 percent).
Growing popularity of bioactive ceramics is another major trend for the global market. This is due to the growing demand from dental sector. According to the National Bureau of Statistics of China, in 2019, patients in China received approximately 3.1 million dental implants, showing a growing trend in the recent years. It was estimated that over 600 million people in China were suffering from dental problems, yet the diagnosis and treatment rates remained low.
Global Bioactive Materials Market: Competitive Landscape
Arthrex Inc, Bioactive Bone Substitutes OyJ, Biomatlante, DSM, Cam Bioceramics, Ceraver, DePuy Synthes (Johnson and Johnson), Medtronic Inc., Noraker, Pulpdent Corporation, Septodont Holding, Stryker Corporation, Zimmer Holdings Inc, Collagen Matrix Inc., OSARTIS GmbHm, Evonik Industries AG, and Boston Scientific Corporation
Global Bioactive Materials Market: Recent Developments
In April 2022, Medtronic and GE Healthcare announced a partnership to address the specific needs and demand for treatment in ambulatory surgery centers (ASCs) and office-based laboratories (OBLs).
In March 2022, Evonik Industries commercially launched EUDRATEC Fasteric used for enteric fortification and prompt release in the upper smaller intestine, which is a platform of oral drug delivery technology directly over the released target.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.View All Our Clients